Inositol 1,4,5-trisphosphate (IP3)-mediated calcium (Ca 2+) signaling is subject to cytosolic and luminal regulatory mechanisms. In Xenopus oocytes, Ca2+-sensitive gating of the IP3 receptor (IP3R) produces repetitive waves of Ca 2+ release. We examined the role of the luminal Ca2+-binding protein calreticulin (CRT) in IP3-mediated Ca 2* signaling by using Ca 2* wave activity as a sensitive Ca 2÷ release assay. Overexpression of CRT inhibited repetitive IP3-induced Ca 2+ waves. Deletion mutagenesis demonstrated that CRT inhibition was mediated by the high affinity-low capacity Ca 2+-binding domain, which contributes little to Ca 2+ storage. This novel function of CRT in intracellular Ca 2÷ signaling may be regulated by Ca 2+ occupancy of the high affinity binding site.
Introduction
Intracellular Ca 2+ release is a point of convergence for many hormone receptor signaling pathways (Berridge, 1993; Pozzan et al., 1994; Putney and Bird, 1993; Tsien and Tsien, 1990) . Oscillations in intracellular Ca 2+ arise from activation of either inositol 1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors. The Ca 2+ sensitivity of both activated receptors is such that at low concentrations, Ca 2÷ induces Ca 2+ release (CICR), while at higher concentrations, Ca 2+ is inhibitory (Bezprozvanny et al., 1991; Finch et al., 1991; lino, 1990) . In Xenopus oocytes, only IP3Rs appear to be expressed (Callamaras and Parker, 1994; Parys et al., 1992) , and their activation leads to complex spatiotemporal patterns of repetitive Ca 2+ release (Lechleiter et al., 1991; Lechleiter and Clapham, 1992; Parker and Yao, 1991) . Although the general properties of Ca 2+ release can be described by the dependence of the IP3-bound IP3R ion channel on Ca 2+, regulation may be more complex. We have previously demonstrated that cytoplasmic clearing and refilling of the stores by Ca 2+-ATPases increases the frequency of the propagating waves of Ca 2+ release (Camacho and Lechleiter, 1993) . Changes in IP3 concentration can also modulate the desensitization of the IP3R ion channel (Hajn6czky and . In addition, luminal Ca 2+ concentration may be an important determinant of channel activity (Missiaen et al., 1992) .
Ca2+-binding proteins located in the lumen of the endoplasmic reticulum (ER) are potential regulators of intracellular Ca 2÷ release (Brillantes et al., 1994; Ikemoto et al., 1989; Kawasaki and Kasai, 1994; Michalak et al., 1992) .
In muscle cells, the predominant ER luminal Ca2+-binding protein is calsequestrin, where it is thought to reduce the Ca 2÷ gradient against which the Ca2+-ATPases must work to refill the stores (Lytton and MacLennan, 1991) . In nonmuscle cells, the predominant Ca2+-binding protein in the ER lumen is calreticulin (CRT) (Milner et al., 1991) . CRT is a highly conserved 400 amino acid peripheral membrane protein of the ER lumen (Michalak et al., 1992) . Like calsequestrin, CRT has a large stretch of negatively charged residues at the COOH-terminus (C domain) that binds Ca 2+ with low affinity (K~ = 0.3-2.0 mM) and high capacity (Br, ax = 20-50 mol/mol of protein) (Michalak et al., 1992) . On the basis of this sequence similarity, the presumed role of CRT in intracellular Ca 2+ release has been luminal Ca 2+ storage (Michalak et al., 1992) . In support of this, decreased expression of CRT in NG-108-15 cells lowered the Ca 2+ response to the agonist bradykinin, suggesting a relationship between CRT levels and Ca 2+ storage capacity (Liu et al., 1994) . CRT also has a high affinity (Kd = 1.6 #M), low capacity (Br,~ = 1 mol/mol of protein) Ca2+-binding domain (P domain) (rBaksh and M ichalak, 1991; Michalak et al., 1992) , although the function of this domain in Ca 2÷ signaling is unknown. This domain consists of a charged region containing a 17 amino acid repeat (PxxlxDPDAxKPEDWDE), followed by a proline, serine, and threonine-rich segment. The NH2-terminal domain of CRT forms a globular domain with a helix-turnhelix motif and does not bind Ca 2÷ . This domain may be involved in the CRT-induced inhibition of transcription by steroid hormone receptors (Burns et al., 1994; Dedhar et al., 1994) .
In this study, we examine the role of the luminal Ca 2+-binding protein CRT in the regulation of IP3-mediated Ca 2+ release. CRT has been postulated to participate in intracellular Ca 2+ signaling on the basis of its ability to store Ca 2+ within the C domain. Here, we directly test this hypothesis by examining the effects of CRT overexpression on IP3-induced repetitive Ca 2+ wave activity in Xenopus oocytes. Surprisingly, we found that CRT does not affect the peak amplitude of IP3-mediated Ca 2÷ release. However, CRT overexpression does reduce the occurrence and frequency of repetitive Ca 2+ wave activity. By deletion mutagenesis analysis of CRT, we show that these inhibitory effects are mediated by the P domain of CRT. We conclude that CRT directly (or indirectly, via accessory proteins) interacts with either the IP3R or Ca2+-ATPases. We also propose that the high affinity Ca2+-binding site of CRT behaves as a luminal Ca 2+ sensor for store depletion.
Results

Overexpression of CRT Inhibits Repetitive Ca 2÷ Waves
To test the role of CRT in IP3-mediated Ca 2~ signaling, oocytes from albino Xenopus laevis were injected with mRNA encoding rabbit CRT (Fliegel et al., 1989) (D) Coexpression of CRT with SERCA2b strongly inhibits IPa-induced Ca 2+ wave activity. Slow frequency repetitive waves are also observed from 180 s to 300 s. This oocyte would be classified as.a mixed wave response (Ca 2÷ tide and repetitive waves; see Table 1 ). Individual confocal images (725 ~rn x 725 ~m) of Ca 2÷ wave activity were taken at the indicated times. The bottom trace in each panel represents the change in fluorescence (AF/F) for a 5 x 5 pixel area (indicated as a white square in the first panel of each experiment) shown as a function of time. Note that the initial rate of rise of the AF/F trace is due primarily to the injection of IP3.
sayed for IP3-induced C a 2+ w a v e activity 4 -6 days after m R N A injection. Confocal i m a g e s of intracellular C a 2÷ w e r e recorded from a single optical slice n e a r the p l a s m a m e m b r a n e surface at 1 s intervals. In control oocytes injected with H20 instead of m R N A , IP3 ( -300 nM final concentration) initiated a large w a v e of C a 2÷ release enveloping the o o c y t e ( Figure 1A ). This Ca 2÷ tide (Tsien and Tsien, 1990 ) w a s followed by repetitive Ca ~÷ w a v e s in 5 7 % of control o o c y t e s (Table 1 ; cf. C a m a c h o and Lechleiter, 1993; Lechleiter and C l a p h a m , 1992). W h e n CRT was expressed, the n u m b e r of o o c y t e s exhibiting repetitive C a 2÷ w a v e s was r e d u c e d (Table 1 ). The majority of CRTe x p r e s s i n g o o c y t e s s h o w e d only the initial tide of C a 2÷ (Figure 1 B) . Additionally, in those mRNA-injected oocytes that displayed repetitive C a 2÷ wave activity (45S/o), the period between successive w a v e s was nearly double that of Mean _+ SEM (n), total number of oocytes in each category. Percent is the percent of (n).
Represents the largest increase (AF) in Ca 2÷ signal from resting fluorescence (F) throughout the entire recording period. b Oocytes with initial large wave (Ca 2+ tide) followed by repetitive waves of Ca 2÷ release. We define repetitive activity as any oscillatory increase in Ca 2÷ subsequent to the initial Ca 2÷ tide. c Subpopulation of oocytes in which fluorescence was calibrated (see Experimental Procedures). CRT is not equivalent to H20 (p < 0.025) (t test). e SERCA2b plus CRT is not equivalent to SERCA2b plus H20 (p < 0.025). f SERCA2b plus AC is not equivalent to SERCA2b plus H20 (p < 0.1). g SERCA2b plus AP is not equivalent to SERCA2b plus H20 (p < 0.025).
control oocytes (p < 0.005; Table 1) , Surprisingly, despite the proposed role of CRT in storage of luminal Ca 2÷, overexpression of CRT did not increase the amplitude of Ca 2÷ waves, suggesting that luminal Ca 2+ storage may not be important for the inhibitory action of CRT (see Table 1 ).
CRT Inhibits the High Frequency Repetitive Activity Elicited By Ca2+-ATPase Overexpression
To increase the sensitivity of our Ca 2+ assay for CRT function, we took advantage of our previous findings showing that overexpression of sarcoendoplasmic Ca2+-ATPases (SERCA1) increases the frequency of iP3-induced Ca 2÷ waves (Camacho and Lechleiter, 1993) . When SERCA1 expression is h igh, no initial tide of Ca 2÷ release is detected in response to a bolus injection of IP3, and repetitive activity is immediately observed. We expressed SERCA2b mRNA in this experiments, since this Ca2÷-ATPase isoform, just as CRT, is preferentially expressed in nonmuscle cells (Gunteski-Hamblin et al., 1988; Milner et al., 1991) . Figure  1C shows the IP3-induced Ca 2÷ wave activity of an oocyte expressing SERCA2b. Oocytes expressing SERCA2b display high frequency repetitive activity in response to IP3, with no initial Ca 2÷ tide (97%). CRT was also inhibitory in this enhanced background of repetitive Ca 2÷ wave activity ( Figure 1D ). Coexpression of CRT with SERCA2b produced a larger number of oocytes exhibiting an initial tide of Ca 2÷ followed by repetitive activity at significantly lower frequency (p < 0.025). Furthermore, 21% of the oocytes now showed only an initial tide of Ca 2÷ release with no repetitive activity ( Table 1) . Inhibition of repetitive Ca 2÷ waves by CRT was observed in the absence of any change in Ca 2÷ wave amplitude, even though the wave amplitude in SERCA2b-expressing oocytes was significantly increased over that in control oocytes (p < 0.01, Table 1 ). Since CRT overexpression did not affect the peak amplitude of the Ca 2+ response, we suggest that CRT itself may behave as a regulator of Ca 2+ release.
The High Affinity-Low Capacity Ca2+-Binding Domain of CRT Inhibits Repetitive Ca 2* Waves
To determine which domain of CRT is responsible for the inhibition of repetitive Ca 2÷ wave activity, we expressed SERCA2b with deletion mutants of CRT in which either the low affinity-high capacity domain (AC mutant), the high affinity-low capacity domain (AP mutant), or both Ca2+-binding domains (APC mutant) were removed. Since wild-type CRT contains the ER-targeting KDEL motif at the COOH-terminus (Munro and Pelham, 1987; Pelham, 1988) , all mutants were engineered with this motif to ensure proper targeting. In vitro translations were carried out in rabbit reticulocyte lysate to demonstrate that the mRNAs encoding mutated proteins yielded appropriately sized product (Figure 2A ). Western blot analysis demonstrated comparable levels of SERCA2b expression in oocytes when coexpressed with wild-type CRT or with the deletion mutants ( Figure 2B) , Western blot analysis also demonstrated expression of CRT, AC, and AP in the same oocyte extracts that were probed with anti-SERCA antibody ( Figure 2C ). Dual labeling confocal immunofluorescence confirmed that CRT, AC, AP, and •PC mutants were correctly expressed in the ER and colocalized with SERCA2b ( Figure 3) .
Our data show that CRT overexpression does not increase the amplitude of IP3-induced Ca 2÷ waves (Table 1) . Expression of the AP mutant should directly test whether the inhibitory action of CRT is due to an increase in the available pool of releasable luminal Ca 2÷, since deletion of the P domain should not significantly affect the Ca 2+-binding capacity of CRT. On the other hand, if CRT directly (or indirectly, via accessory proteins) regulates Ca2÷-ATPases or IP3Rs, the AC mutant may mimic the effects of CRT on repetitive Ca 2+ wave activity, by analogy with the role of high affinity Ca2+-binding sites in other Ca2+-binding proteins (Nash et al., 1994) . Indeed, we found that expression of the AP mutant with SERCA2b ( Figure  4A ) did not inhibit Ca 2+ repetitive activity. Only 1 of 35 SERCA2b-AP-expressing oocytes tested failed to exhibit repetitive Ca 2÷ waves (Table 1 ). The AP mutant also had no effect on wave amplitude, although we did observe an increase in the interwave period. By contrast, when the AC mutant was coexpressed with SERCA2b, IP3-induced Figure 1 ). (D) Schematic diagram of expression constructs for wild-type CRT and deletion mutants (N, P, and C are CRT domains as described in the text; KDEL is the COOH-terminus ER retention signal in wild-type CRT and CRT deletion mutants). Circles depict Ca2÷-binding sites. Amino acids (in single letter code) indicate boundaries between domains for each mutant.
repetitive Ca 2÷ wave activity was markedly reduced ( Figure  4B ). Nearly half of the SERCA2b-AC-expressing oocytes screened failed to show repetitive activity (Table 1 ). To rule out the possible involvement of the CRT region that contains no Ca2÷-binding domains (N domain; Figure 4D ), we also coexpressed SERCA2b with the APC mutant. No effect on I P3-induced Ca 2÷ wave activity was observed (Figure 4C ; Table 1 ). These data demonstrate that the P domain is not only sufficient but also necessary for CRT inhibition of IP3-induced repetitive Ca 2+ waves.
Discussion
Our studies demonstrate that CRT regulates intracellular Ca 2+ signaling via the P domain. Interestingly, this domain of CRT is highly homologous to calnexin, a chaperone protein of the ER (Bergeron et al., 1994) . Recent reports indicate that CRT may also act as a molecular chaperone (Nauseef et al., 1995; Nigam et al., 1994) . We suggest that interactions of the P domain with either the Ca 2÷-ATPase or the IP3R, directly or via an intermediary protein, could account for the inhibition of repetitive Ca 2+ waves by CRT. In the first case, inhibition of Ca2+-ATPases would inhibit cytosolic Ca 2+ clearing, preventing repetitive Ca 2+ wave activity subsequent to the initial Ca 2÷ tide. We have previously demonstrated that the refilling of Ca 2+ stores by overexpression of Ca2+-ATPases shortens the refractory period of Ca 2÷ release subsequent to excitation (Camacho and Lechleiter, 1993) . Alternatively, CRT could stabilize the open conformation of the IP3R, prolonging Ca 2+ release. The latter mechanism has been proposed for the regulation of the ryanodine receptor by the molecular chaperone FKBP12 (Brillantes et al., 1994) . FKBP12 has also been shown to be associated with the IP3R and to increase the Ca 2+ flux through this ion channel (Cameron et al., 1995) . Further, CRT copurifes with IP3R in rat liver (Enyedi et al., 1993) and has a similar distribution to that of IP3R in Xenopus oocytes (Parys et al., 1994) , placing the two proteins in proximity for a putative functional interaction. The Ca 2÷ binding to the high affinity P domain may have a regulatory function. It is unlikely that the high affinity Ca2÷-binding site is occupied when Ca 2+ stores are depleted. We propose that the physiological function of CRT is to prolong an IP3-induced rise in cytosolic Ca 2+, but only when Ca 2÷ stores are full and the high affinity Ca2÷-binding domain is saturated. When Ca 2+ stores are depleted and the high affinity domain is unoccupied, CRT regulation may be removed, and the flux of Ca 2÷ could then shift in favor of store refilling. The luminal regulation of IP3-mediated Ca 2+ release by CRT could operate independently of the cytosolic regulation of the IP3R by Ca 2÷. Alternatively, CRT could shift the Ca 2÷ dependency of the IP3-bound receptor, such that higher concentrations of Ca 2+ are needed to close the ion channel. Thus, the excitatory mechanism of CICR would still generate a propagating wave of Ca 2÷ release. However, individual waves would be terminated more slowly (if at all) by CRT, since inhibition of channel gating is less sensitive to high levels of cytosolic Ca 2+. Regardless of the precise regulatory mechanism of CRT, our data now require that the function of CRT in intracellular Ca 2+ signaling be viewed beyond its ability simply to sequester Ca 2+.
Experimental Procedures
Construction of Expression Vectors cDNAs encoding CRT and SERCA2b were subcloned between the 5' and 3' untranslated regions (5'UTR and 3'UTR) of Xenopus I~-globin expression vector (Melton et al., 1984) (expression vector pGEM-HE-Not, gift of E. Liman). We used the polymerase chain reaction (PCR) to amplify the full-length cDNA encoding rabbit CRT from plasmid pcDX-CRT (gift of M. Michalak). The forward primer in the PCR reaction had sequence 5'-ATCGGAATTCGCCATGCTCCCTGTG-CCG-3' and incorporated an EcoRI site at the 5' end ,of CRT. The reverse primer sequence had sequence 5'-ATCGAAGCTTCTCTA-CAGCTCGTCCTTGGCC-3', incorporating a Hindlll site at the 3' end of CRT (all primers synthesized by Operon Technologies). The CRT PCR product was gel-isolated, digested with EcoRI and Hindlll, and subcloned into expression vector pGEM-HE-Not. To express the SERCA2b Ca2÷-ATPase, we used PCR to amplify the full open reading frame from the cDNA RB 2-5, encoding SERCA2b (gift of G. Shull), The forward primer in the PCR reaction had sequence 5'-ATGCG-GATCCGCCATG GAGAACGCTCACACAAAGACCG-3', incorporating a BamHI site at the NH2-terminus of the SERCA2b-encoding cDNA. The reverse oligo, with sequence 5'-ATGCAAGCTTGCGCTGTCAGT-CAAGACC-3', incorporated a Hindlll site at the 3' end of the SERCA2b cDNA. Following PCR amplification, the PCR product was gel-isolated and digested with BamHI and Hindlll. The PCR fragment was subcloned into the vector pGEM-HE-Not, described above, digested with BamHI and Hindlll. The resulting plasmid pSERCA2b-HE-Not contains the cDNA encoding SERCA2b between the 5'UTR and the 3'UTR of Xenopus ~-globin.
Expression vector for the AP mutant was made by digesting plasmid pCRT-HE-Notl (described above) with Bcll and BamHl. Following removal of the 399 bp fragment (BclI-BamHI), the vector retaining the N domain and the C domain was religated to obtain plasmid pCRT-AP-HE-Not. The vector to express the AC mutant was engineered by PCR using pcDX-CRT as a template and the 5' forward primer described in Figure 1 in conjunction with the reverse primer (5'-GTCG-ATCTGCCCGGGCTTCCACTCACC-39, which creates a silent Smal site overlapping the amino acid sequence GEWKPRQ. A PCRamplified product of 840 nt (EcoRI-Smal) was digested with Nael and Smal, and the 486 nt fragment NaeI-Smal was subcloned into the plasmid pCRT-HE-Not, which was digested with Nael (to remove the NaeI-Nael fragment) and dephosphorylated with calf intestinal phosphatase (Boeringer Mannheim). Restriction digest analysis was used to select the recombinant with the correct orientation. This was confirmed by sequencing the template. The resulting plasmid, pCRT-AC-HE-Not, retains domains N and P and terminates with the KDEL motif of the wild-type CRT. We constructed plasmid pCRT-APC-HE-Not to express a CRT mutant lacking the P and C domains. Plasmid pCRT-HE-Not, described above, was digested with Nael to remove a NaeI-Nael -899 bp fragment encoding domains P and C. The vector was religated, retaining only the N domain end the KDEL motif at the COOH-terminus of wild-type CRT. The boundaries between N, P, and C domains of CRT deletion mutants were sequenced with following primers. Primer 5'-GCTACGTGAAGCTGTTT-3'was used to sequence the boundary between the N and the P domain (in the AC mutant), the boundary between the N and the C domain (in the AP mutant), and the terminal KDEL following the N domain (in the APC mutant). Primer 5'-TCGGGGCGAGTACTCATG-3', complementary to the C domain, was used to sequence the boundary between the N and the C domains (in the Ap mutant). Finally, primer 5'-GCTTAGAGACTCCATTC-3', complementary to the 3'UTR of Xenopus 13-globin (in the expression vector), was used to sequence the COOH-terminus of all mutants.
In Vitro Transcriptions
Plasmids encoding CRT (pCRT-HE-Not), •C (pCRT-AC-HE-Not), Ap (pCRT-AP-HE-Not), APC (pCRT-APC-HE-Not), and SERCA2b Ca 2+-ATPase (pS2A-HE-Not) were linearized before transcription (Nhel and Notl, respectively) . Capped synthetic mRNA transcripts were carried out with the T7 MegaScript kit (Ambion) according to the instructions of the manufacturer. Synthetic mRNAs were resuspended at a concentration of 1.5-2.0 ~g/p.l. Aliquots of 3 t~l each were stored at -70°C until injected into Xenopus oocytes (50 nl bolus).
Western Blot Analysis
Oocyte extracts used in Western blots were prepared from pools of five to ten oocytes as previously described (Camacho and Lechleiter, 1993) , except that a freon extraction was carried out to remove yolk proteins (Evans and Kay, 1991) . The final pellet of each extract was resuspended in 6-9 ~1 of 1% SDS per oocyte equivalent, stored frozen in aliquots of one oocyte equivalent each.
In Vitro Translations/Biotinylations
In vitro translations/biotinylations we re carried out in rabbit reticulocyte lysate (Boehringer Mannheim) according to instructions from the manufacturer. Synthetic mRNAe (3-6 p.g each) encoding CRT, AC and AP, and APC were used as input in a 50 p.I volume reaction.
Confocal Ca 2. Imaging Ca 2+ was imaged as previously described (Camacho and Lechleiter, 1993) . In brief, oocytes were injected with a solution of calcium green I (50 nl, 250 I~M) 30-60 min prior to each experiment (-12.5 p_M final concentration, assuming a 1:20 dilution). Images (170 x 170 pixels or 256 x 256 pixels) were acquired with a Bio-Rad M RC 600UV confocal laser scanning microscope at zoom 1.5 attached to a Nikon Diaphot with a 10x (0.5 NA) UVfluor Nikon objective lense at 1 s intervals; we used Time Course/Ratiometric Software (TCSM; Bio-Rad). The confocal aperture was set at the largest opening, producing a 745 x 745 x 32 pm optical slice. Images were analyzed with ANALYZE (Mayo Foundation) on a Sun Sparc2 workstation. Images were not filtered for analysis or display. Ca ~÷ increases are reported as AF/F, which represents (Fpeak -Fr~t)/Fre,,. On a subpopulation of oocytee, an in vivo calibration was carried out at the end of an experiment by injecting a 50 nl bolus of 200 mM CaCI2 and 20 p.M thapsigargin to obtain a F,~. Fr,~, was estimated as 0.26 x Fma×, on the basis of in vitro measurements of fluoresence intensity with (40 I~M) or without (1 mM EGTA) Ca 2.. A Kd of 150 nM was used for calcium green I. Ca 2+ wave activity was induced by injecting a bolus of 50 nl of IP3 (Calbiochem) at 6 p.M (-300 nM final concentration, assuming 1:20 dilution). All recordings were made in the absence of extracellular Ca 2+ (96 mM NaCI, 2 mM KCI, 2 mM MgCI2, 5 mM HEPES [pH 7.5] [GIBCO], 1 mM EGTA [Sigma]).
Immunofluorescence
Individual oocytes were saved for immunofluorescence to detect expression and targeting of CRT and deletion mutants. Oocytes were fixed in 4% paraformaldehyde, 3% sucrose solution for 2 hr at 4°C. To remove fixative and initiate rehydration, oocytes were washed twice in 20% sucrose, 0.1 M phosphate buffer followed by incubation with shaking for 2 hr at 4°C. Oocytes were embedded in acrylamide according to the protocols of Hausen and Dreyer (1991) , frozen in a dry ice-EtOH bath, and sectioned in 20 I~m slices at -20°C. Slices were mounted on glass slides, and nonspecific binding was blocked with 2% blocking reagent (Boeringher) and 10% horse serum in 1 x TBS solution. Oocytes were incubated for 1-2 hr with a rabbit anti-human CRT primary antibody (1:30 dilution, Ab PA3-900; Affinity BioReagents). After primary antibody had been washed three times in 1 x TBST, oocyte slices were incubated with LRSC-anti-rabbit secondary antibody (1:30 dilution; Jackson Laboratories). Secondary antibody was washed again as described above, and the slides were mounted in media containing buffered (pH 8.5) polyvinyl alcohol (Mowiol, Calbiochem) prepared according to the protocols of Osborne and Weber (1982) . Anti-fading agent (n-propyl gallate, or NPG; Sigma) was added to the mounting medium at a concentration of 20 g/I (Longing et al., 1993) . For double-labeling immunofluorescence, five groups of oocytes were injected with mRNA to coexpress SERCA2b, with CRT, AC, AP, APC, or H~O for control, and were prepared for immunofluorescence as described above. Labeling of CRT and CRT deletion mutants is described above. To label SERCA2b, we used a rabbit primary antibody, C-4 (gift of D. MacLenan; this antibody recognizes all rat SERCA pumps). Because both primary antibodies in the dual labeling experiment are from the same host species (rabbit), we used a conjugated Fab fragment for labeling and blocking the first antigen (Jackson Laboratories, example A). To label the SERCA2 antigen, the oocyte slices were incubated with C-4 antibody for 60 min at 1:500 dilution in 1% blocking reagent and 10% don key serum (Jackson Laboratories). Following four washes of 3 min each in TBST, incubation with fluorescein ieothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G (H plus L) (Jackson Laboratories) was performed for 60 rain at 1:17 dilution. After four washes of 3 rain each in 1 x TBST, a second blocking step was added (1% blocking reagent, 10% donkey serum) for 30 min. To label the second antigen, the slices were incubated with rabbit anti-hCRT primary antibody lAb PA3-900) at 1:100 dilution in 1% blocking reagent, 10o/0 donkey serum in 1 x TBS. Following a cycle of four washes as above, incubation with the lysamine-rhodamine (LRSC) donkey anti-rabbit secondary antibody was performed for 60 min at a 1:50 dilution. Following a final wash cycle, the slices were mounted as described above. The following controls (not all shown) were performed in the dual labeling experiment. Control 1, no primary CRT antibody, with LRSC secondary antibody; control 2, no C-4 or PA3-900 primary antibody; control 3, C-4 primary antibody plus Fab FITC; control 4, PA3-900 primary antibody plus LRSC-conjugated secondary; and finally, control 5 only with LRSC-conjugated secondary antibody, without either of the two primary antibodies. Stained sections were imaged with a Bio-Rad MRC 600UV confocal microscope adapted to a Nikon Diaphot 200 and a Nikon fluor1.3 oil 100 x objective using a fluoroscein and rhodamine filter set (T1/T2A filter cubes from Bio-Rad) combined with an argon/krypton laser.
